Dashboard
Portfolios
Watchlist
Community
Discover
Screener
MU
mukesh_l8vbw
Community Contributor
Member since 2026
Views
0
Total number of views
Fair Values Set
0
Total number of fair values set
Comments
1
Total number of comments
Followers
0
Total number of followers
No bio added yet
No link added
Narratives
Watchlists
Portfolios
Discussions
Likes
HALO
·
about 2 hours ago
Analysts Reassess Halozyme Therapeutics Amid Mixed Sentiment and Slight Valuation Adjustments
Based on 2026 guidance the forward PE for 2026 is ~10! So surprised you only mentioned a high trailing PE unless you think their guidance is BS.
0
|
0